![Robert J. Towarnicki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert J. Towarnicki
Corporate Officer/Principal bij
Biotechnology Innovation Organization
Profiel
Robert J.
Towarnicki currently works at Biotechnology Innovation Organization, as Member.
Mr. Towarnicki also formerly worked at Cell Pathways, Inc., as Chief Executive Officer, Nucleonics, Inc., as President & Chief Executive Officer from 2003 to 2009, SIRPant Immunotherapeutics, Inc., as President, Chief Executive Officer & Director, Merck & Co., Inc., as Principal, Integra LifeSciences Holdings Corp., as Principal, Collagen Corp., as Vice President, Quest Diagnostics Infectious Disease, Inc., as General Manager, and Pfizer Pharmaceuticals, Inc., as Operations Manager.
Mr. Towarnicki received his undergraduate degree and graduate degree from Villanova University.
Actieve functies van Robert J. Towarnicki
| Bedrijven | Functie | Begin |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | - |
Eerdere bekende functies van Robert J. Towarnicki
| Bedrijven | Functie | Einde |
|---|---|---|
SIRPant Immunotherapeutics, Inc.
 SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Algemeen Directeur | 01-08-2024 |
Nucleonics, Inc.
 Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA interference-based therapeutics | President | 04-12-2009 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Operationeel Directeur | - |
Collagen Corp.
 Collagen Corp. BiotechnologyHealth Technology Develops biomedical products from mammali | Corporate Officer/Principal | - |
Opleiding van Robert J. Towarnicki
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
89
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Integra LifeSciences Holdings Corp.
 Integra LifeSciences Holdings Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices, implants and biomaterials | Health Technology |
Cell Pathways, Inc.
 Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat cancer | Health Technology |
Nucleonics, Inc.
Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA interference-based therapeutics | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Collagen Corp.
Collagen Corp. BiotechnologyHealth Technology Develops biomedical products from mammali | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quest Diagnostics Infectious Disease, Inc.
 Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Provides diagnostic services | Commercial Services |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Health Technology |
